Le Lézard
Classified in: Health
Subjects: CHI, WOM, AVO, DEI

Consumers for Dental Choice Salutes Worldwide Decision to Protect Children and Pregnant Women from Mercury Dental Fillings


WASHINGTON, April 1, 2022 /PRNewswire/ -- In a stunning turn of world opinion, the nations of the world have united to call for ending dental amalgam use in children and women who are pregnant or breastfeeding.

Dental amalgam is a controversial filling material that is approximately 50% mercury (although deceptively marketed as "silver fillings"). On 26 March, at the 4th Conference of the Parties to the Minamata Convention on Mercury, a treaty of more than 130 nations, the Parties unanimously agreed to an amendment requiring countries to protect vulnerable populations from further use of dental amalgam:

"...Exclude or not allow, by taking measures as appropriate, or recommend against the use of dental amalgam for the dental treatment of deciduous teeth [baby teeth], of patients under 15 years and of pregnant and breastfeeding women..."

Charlie Brown, president of the World Alliance for Mercury-Free Dentistry and executive director of Consumers for Dental Choice, hailed the action: "The world unites to say that mercury is not safe in the mouths of children and their mothers ? and its use must stop, this year."

"We salute the nations of Africa, all 54 of them, for initiating and presenting this splendid proposal," Brown said.  "Too, we praise the World Health Organization for calling for a worldwide switch to 'minimally-invasive' and mercury-free dental materials." 

Brown added that manufacturers and distributors of this toxic product are on notice to stop selling amalgam ? because once they sell it, much of it is implanted into children, pregnant women, and breastfeeding mothers. 

"Dentists must stop placing amalgam in children and in young women ? now." Brown cautioned. "This new amendment represents a worldwide consensus that dental amalgam is not safe for children and other vulnerable populations ? it is not safe in their mouths and it is not safe in their environment." 

The US Food and Drug Administration, since 2020, and Health Canada, since the 1990s, already recommend the end of amalgam use for children and for pregnant women.

Contact Charlie Brown, 202.246.7642 (cell), 202.544.6333 (ofc.)

SOURCE Consumers for Dental Choice


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: